{
  "subset": "contraindication",
  "disease": "Neurotransmitter disorders",
  "relation": "contraindication",
  "gold_drugs": [
    "posiphen",
    "sgs-742"
  ],
  "seeds_initial": [
    "Fluoxetine",
    "Paroxetine",
    "Venlafaxine",
    "Bupropion",
    "Citalopram",
    "Clomipramine",
    "Sertraline",
    "Duloxetine",
    "Amitriptyline",
    "Nortriptyline",
    "Desipramine",
    "Trimipramine",
    "Buspirone",
    "Carbamazepine",
    "Lamotrigine",
    "Valproate",
    "Phenelzine",
    "Selegiline",
    "Moclobemide",
    "Rasagiline",
    "Lithium",
    "Clonazepam",
    "Diazepam",
    "Lorazepam",
    "Alprazolam",
    "Topiramate",
    "Tiagabine",
    "Oxcarbazepine",
    "Gabapentin",
    "Pregabalin",
    "Lacosamide",
    "Zonisamide",
    "Asenapine",
    "Clozapine",
    "Olanzapine",
    "Quetiapine",
    "Risperidone",
    "Ziprasidone",
    "Aripiprazole",
    "Paliperidone",
    "Brexpiprazole",
    "Cariprazine",
    "Tranylcypromine",
    "Chlordiazepoxide",
    "Hydroxyzine",
    "Promethazine",
    "Prochlorperazine",
    "Metoclopramide",
    "Dexamethasone",
    "Prednisone",
    "Fenfluramine",
    "Dronabinol",
    "Sodium Oxybate",
    "RimabotulinumtoxinB",
    "Botulinum toxin A",
    "Cannabidiol",
    "Methysergide",
    "LSD",
    "Methylphenidate"
  ],
  "seed_history": [
    [
      "Fluoxetine",
      "Paroxetine",
      "Venlafaxine",
      "Bupropion",
      "Citalopram",
      "Clomipramine",
      "Sertraline",
      "Duloxetine",
      "Amitriptyline",
      "Nortriptyline",
      "Desipramine",
      "Trimipramine",
      "Buspirone",
      "Carbamazepine",
      "Lamotrigine",
      "Valproate",
      "Phenelzine",
      "Selegiline",
      "Moclobemide",
      "Rasagiline",
      "Lithium",
      "Clonazepam",
      "Diazepam",
      "Lorazepam",
      "Alprazolam",
      "Topiramate",
      "Tiagabine",
      "Oxcarbazepine",
      "Gabapentin",
      "Pregabalin",
      "Lacosamide",
      "Zonisamide",
      "Asenapine",
      "Clozapine",
      "Olanzapine",
      "Quetiapine",
      "Risperidone",
      "Ziprasidone",
      "Aripiprazole",
      "Paliperidone",
      "Brexpiprazole",
      "Cariprazine",
      "Tranylcypromine",
      "Chlordiazepoxide",
      "Hydroxyzine",
      "Promethazine",
      "Prochlorperazine",
      "Metoclopramide",
      "Dexamethasone",
      "Prednisone",
      "Fenfluramine",
      "Dronabinol",
      "Sodium Oxybate",
      "RimabotulinumtoxinB",
      "Botulinum toxin A",
      "Cannabidiol",
      "Methysergide",
      "LSD",
      "Methylphenidate"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_fluoxetine",
          "name": "Fluoxetine"
        },
        "score": 0.56,
        "graph_snapshot_ref": "GE_H1_round2",
        "key_assumptions": [
          "Fluoxetine 与神经递质障碍有禁忌关系",
          "安全性与疗效之间存在平衡"
        ],
        "caveats": [
          "不良反应风险需进一步证实"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_paroxetine",
          "name": "Paroxetine"
        },
        "score": 0.56,
        "graph_snapshot_ref": "GE_H2_round2",
        "key_assumptions": [
          "Paroxetine 与神经递质障碍有禁忌关系",
          "安全性与疗效之间存在平衡"
        ],
        "caveats": [
          "不良反应风险需进一步证实"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_venlafaxine",
          "name": "Venlafaxine"
        },
        "score": 0.56,
        "graph_snapshot_ref": "GE_H3_round2",
        "key_assumptions": [
          "Venlafaxine 与神经递质障碍有禁忌关系",
          "安全性与疗效之间存在平衡"
        ],
        "caveats": [
          "不良反应风险需进一步证实"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_bupropion",
          "name": "Bupropion"
        },
        "score": 0.56,
        "graph_snapshot_ref": "GE_H4_round2",
        "key_assumptions": [
          "Bupropion 与神经递质障碍有禁忌关系",
          "安全性与疗效之间存在平衡"
        ],
        "caveats": [
          "不良反应风险需进一步证实"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_citalopram",
          "name": "Citalopram"
        },
        "score": 0.56,
        "graph_snapshot_ref": "GE_H5_round2",
        "key_assumptions": [
          "Citalopram 与神经递质障碍有禁忌关系",
          "安全性与疗效之间存在平衡"
        ],
        "caveats": [
          "不良反应风险需进一步证实"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Neurotransmitter disorders (contraindication)",
          "reason": "多种药物与神经递质障碍的禁忌关系明确"
        }
      ],
      "remaining_gaps": [
        "需确认不良反应风险的真实影响"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": [
        "需进一步研究确认药物的安全性和疗效平衡",
        "避免药物的不良反应对治疗效果的负面影响"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "加强对约5种禁忌药物的安全性与疗效研究"
      },
      {
        "role": "Skeptic",
        "patch": "提供不良反应的证据以支持禁忌推论"
      }
    ],
    "heuristics": [
      {
        "when": "神经递质相关障碍",
        "then": "考虑药物的禁忌情况和不良反应"
      }
    ]
  }
}